The LIFT-ECHO Last Mile Project for Intestinal Failure

This study, called The LIFT-ECHO Last Mile Project, is looking at how well a virtual learning program, LIFT-ECHO (Learn Intestinal Failure Tele-ECHO), helps patients with chronic intestinal failure (CIF) feel better. LIFT-ECHO teaches doctors who aren't specialists how to better care for patients with CIF who are on parenteral nutrition (PN), which is nutrition given through a vein. The study compares patients whose doctors use LIFT-ECHO to those whose doctors provide standard care. We want to see if LIFT-ECHO improves your quality of life, as measured by a Patient-Reported Quality of Life (PRQOL) Score. This study is currently unclear on its recruitment status and aims to enroll 150 participants. You can join if you are 18 or older with CIF, or if you are a child aged 5 or older with CIF and have parental consent.

Study design
This interventional study involves at least 150 groups of doctors, each with at least one patient. Doctors will be randomly assigned to either start with standard care or the LIFT-ECHO program, then switch to the LIFT-ECHO program later.
What's involved
Not specified in the trial record.
Compensation
Not stated in the trial record.
Follow-up
Your quality of life will be checked at the start of the study, at 6 months, and again at 12 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07094308

The LIFT-ECHO Last Mile Project

Not Yet Recruiting
NAAges 5+InterventionalHealth services
Icahn School of Medicine at Mount Sinai
~150 participants
Updated 2026-03-12 on ClinicalTrials.gov
What's tested:Learn Intestinal Failure Tele-ECHO ProgramStandard of Care

At a glance

Recruiting sites
0 of 5 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Patient-Reported Quality of Life (PRQOL) Score
Measured over Baseline, 6 months, and 12 months
Intestinal Failure
5 sites across 4 states
New York2
Rhode Island1
Utah1
United Kingdom1
  • Kishore Iyer, MD · PRINCIPAL_INVESTIGATOR · Icahn School of Medicine at Mount Sinai

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

CIF patient participants must meet the following criteria in order to be considered eligible for participation:
Individuals of adult age (18 years or older), including pregnant women or Individuals of age \> 5 years with parental consent and patient assent.
Diagnosis of chronic intestinal failure (ie. on PN \>6 months with no malignancy, no HIV and a malabsorption or post-surgical diagnosis)
Currently receiving PN from a homecare infusion service company
Physician participants must meet the following criteria in order to be considered eligible for participation:
Individuals of adult age (18 years or older), including pregnant women
Hold an MD or DO degree
Be a licensed physician prescriber with a homecare infusion service company

Exclusion

Participants meeting one or more of the following criteria will be excluded from participation:
Adults unable to consent (individuals with impaired decision-making capacity)
Prisoners
Children \> 5 years who dissent
  • Patient-Reported Quality of Life (PRQOL) ScoreBaseline, 6 months, and 12 months

    Patient-reported quality of life will be measured using the HPN-PROQ, a validated instrument designed for individuals receiving home parenteral nutrition (HPN). The total score ranges from 0 to 100, with higher scores indicating better quality of life. Subscales include physical health, emotional well-being, social functioning, and treatment burden, each also scored from 0 to 100, where higher scores indicate more favorable outcomes